Outcomes for Participants During Long-Term Follow-Up After Discontinuation of Cabotegravir + Rilpivirine Long-Acting in the Phase 3/3b Clinical Trials

Conference Reports for NATAP

18th European AIDS Conference
October 27th-30th, 2021
Online & United Kingdom


Outcomes for Participants During Long-Term Follow-Up After Discontinuation of Cabotegravir + Rilpivirine Long-Acting in the Phase 3/3b Clinical Trials

	EACS 2021 Oct 27-30